Skip to main content
CKD in diabetes

MANAGING CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES - FOCUS ON MRAS

French Version

About this Program

Hear what our multidisciplinary, pan-Canadian expert panel has to say about chronic kidney disease (CKD) in patients with type 2 diabetes (T2D) in the Hallway Huddle. Each 5–10-minute video in this series features one of our experts presenting the latest on screening, guidelines, residual risk, and novel treatments for the management of CKD in T2D.

Important Disclaimer.

Learning Objectives:

  • After this program, participants will be able to:
  • Apply guideline-based screening for chronic kidney disease (CKD) in patients with type 2 diabetes (T2D)
  • Address the residual risk in patients with CKD and T2D above and beyond current therapies
  • Implement disease modifying therapies in patients with T2D and CKD
  • Safely manage potential adverse events, such as hyperkalemia, associated with new therapies

Question 1

When and why should patients with T2D have their UACR tested?
Navdeep Tangri, MD PhD, FRCPC

WATCH

Question 2

What do the guidelines say about managing CKD in T2D?
Alice Y.Y. Cheng, MD, FRCPC

WATCH

Question 3

What are the key differences between steroidal MRAs and nonsteroidal MRAs?
Daniel Ngui, BScPT, PT, MD, CCFP, FCFP

WATCH

Question 4

For which patients should novel nonsteroidal MRAs be considered?
Normand Proulx, MD, FRCP(C)

WATCH

Question 5

What data supports the use of novel nonsteroidal MRAs in patients already on an SGLT2 inhibitor?
Normand Proulx, MD, FRCP(C)

WATCH

Question 6

When and how should potassium levels be monitored and managed in patients on MRAs?
Louise Moist, MD MSc CCPE FRCPC

WATCH

Faculty

Alice Y.Y. Cheng

MD, FRCPC

Endocrinologist, Trillium Health Partners
& Unity Health Toronto
Associate Professor, University of Toronto
Toronto, ON

Normand Proulx

MD, FRCP(C)

Nephrologist, CISSS de l'Outaouais
Pavillon de Hull
Part-time Lecturer, McGill University
Gatineau, QC

Louise Moist

MD, MSc, CCPE, FRCPC
Professor of Medicine Epidemiology and Biostatistics
Nephrologist, London Health Sciences Centre
Deputy Chair, Division of Nephrology
Schulich School of Medicine & Dentistry, Western University
London, ON

Navdeep Tangri

MD, PhD, FRCPC
Attending physician and Associate Professor
Division of Nephrology, Department of Medicine and
the Department of Community Health Sciences
University of Manitoba
Scientific Director, Chronic Disease Innovation Centre
Seven Oaks General Hospital
Winnipeg, MB

Daniel Ngui

BSc, PT, MD, CCFP, FCFP
Clinical Professor, Department of Family Medicine
University of British Columbia
Medical Director, Fraser Street Medical
Vancouver, BC
ukidneyisup